Literature DB >> 13694297

Clinical evaluation of a new alkylating agent: cytoxan (cyclophosphamide).

P R COGGINS, R G RAVDIN, S H EISMAN.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS/therapy

Mesh：

Substances：

Year:  1960        PMID： 13694297     DOI： 10.1002/1097-0142(196011/12)13:6<1254::aid-cncr2820130614>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  4 in total

1.  THE CHEMOTHERAPY OF MALIGNANT DISEASE--PRACTICAL AND EXPERIMENTAL CONSIDERATIONS.

Authors:  J MATTHIAS
Journal:  Postgrad Med J       Date:  1965-05       Impact factor: 2.401

2.  Clinical experience with cyclophosphamide in malignant disease.

Authors:  D A DICK; A F PHILLIPS
Journal:  Can Med Assoc J       Date:  1961-10-28       Impact factor: 8.262

Review 3.  Chemotherapy in colorectal cancer.

Authors:  T J McElwain
Journal:  Proc R Soc Med       Date:  1973-12

Review 4.  Hair disorders in patients with cancer.

Authors:  Azael Freites-Martinez; Jerry Shapiro; Shari Goldfarb; Julie Nangia; Joaquin J Jimenez; Ralf Paus; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2018-04-14       Impact factor: 11.527
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.